Gene Editing SARS-CoV-2 Omicron escapes immune response due to high ACE2 affinity and low antibody specificity Posted on May 11, 2022 by Editorial Staff In a recent study published in the journal Vaccines, researchers revealed how severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron evades neutralizing antibodies (nAbs). Share on FacebookTweetFollow us Editorial Staff Antifungal agent Bifonazole as an antiviral against SARS-CoV-2 Study estimates effectiveness of 2-dose and 3-dose mRNA vaccination against Omicron